Editorial credit: Felix Lipov / Shutterstock.com According to a Federal Trade Commission official, settlements in a law enforcement sweep against CBD marketers send a clear message to the growing sector: Don’t make spurious health claims that are unsupported by medical science.
A handful of marketers of CBD products have agreed to each pay tens of thousands of dollars to the Federal Trade Commission after they were charged with making deceptive claims.
Dubbed “Operation CBDeceit,” the sweep of actions against six sellers of CBD-containing products highlights “the first law enforcement crackdown on deceptive claims” in the CBD market, according to the government agency in a Dec. 17 news release. The sweep also reflects the FTC’s ongoing efforts to protect consumers from deceptive, false and misleading health claims in advertisements on websites and via social media.
Agriculture
your username
December 18, 2020
The Federal Trade Commission (FTC) announced a âlaw enforcement crackdownâ on deceptively marketed CBD products on Thursday. As part of the action, the FTC filed litigation against six companies which sell products containing CBD with claims that they made unsupported marketing claims about the productsâ ability to treat various health conditions.Â
The FTC said it was hoping to send a message to the CBD industry that they should not make claims which are not medically supported, and that if they do, they could face consequences from the FTC. The effort, known as âOperation CBDeceitâ is reportedly just a part of the FTCâs efforts to protect consumers against misleading health claims in advertising and on websites.Â
Trump administration cracks down on claims that CBD can treat cancer, diabetes, Alzheimer’s
Updated Dec 17, 2020;
.
There are all sorts of claims out there about CBD: It can cure cancer. It can protect against Alzheimer’s disease. It can treat autoimmune diseases and autism.
These and other claims about cannabidiol were advertised by companies that sell those products. And they all had one thing in common, according to the Federal Trade Commission: They were false.
The FTC announced on Thursday that it was penalizing six CBD companies for making such claims, including requiring some of them to pay more than $246,000 to the government from shares of their revenues.
FTC enforcement action targets six CBD firms over unsubstantiated claims The Federal Trade Commission unveiled an enforcement action today against six sellers of CBD products that it alleges have been making unsubstantiated disease treatment claims. FTC has levied more than $246,000 in fines in the cases.
The action was announced on the agency’s website this morning. According to the statement, the CBD firms (two firms also market CBG products) were allegedly making a wide range of scientifically unsupported claims about their ability to treat serious health conditions, including cancer, heart disease, hypertension, Alzheimer’s disease, and others.
The six companies will be required to stop making the claims immediately. Fines were levied in all but one of the cases. The fines ranged from $20,000 to $85,000. In addition to the fines the defendants are prohibited in the future from making health benefit claims without competent and reliable sc
Andrew Smith, Director, Bureau of Consumer Protection on Thursday, December 17, 2020.
The Federal Trade Commission today announced the first law enforcement crackdown on deceptive claims in the growing market for cannabidiol (CBD) products. The FTC is taking action against six sellers of CBD-containing products for allegedly making a wide range of scientifically unsupported claims about their ability to treat serious health conditions, including cancer, heart disease, hypertension, Alzheimer’s disease, and others.
The FTC is requiring each of the companies, and individuals behind them, to stop making such unsupported health claims immediately, and several will pay monetary judgments to the agency. The orders settling the FTC’s complaints also bar the respondents from similar deceptive advertising in the future, and require that they have scientific evidence to support any health claims they make for CBD and other products.